Skip to main content
Journal of Hand and Microsurgery logoLink to Journal of Hand and Microsurgery
. 2010 Jan 8;1(2):68–71. doi: 10.1007/s12593-009-0018-3

Patient-centered care of de Quervain’s disease

David Ring 1,, Alexandra Schnellen 1
PMCID: PMC3453032  PMID: 23129936

Abstract

Purpose

To test the hypothesis that most patients that elect symptomatic treatment of de Quervain’s disease experience symptom resolution.

Materials and methods

Eighty-three of 314 (26%) patients that elected initial symptomatic treatment of de Quervain’s disease responded to a mail survey inquiring about symptom resolution, symptom duration, subsequent opinions and treatments, final impressions and comments.

Results

Seventy-five respondents (90.4%) reported resolution of the pain, including 58 of the 61 (95%) respondents that elected neither corticosteroid injection nor surgery. Among patients with symptom resolution without injection or surgery 48 of 58 (83%) recalled symptoms for fewer than 12 months. The differences in reported average time to symptom resolution were not statistically significant between patients that elected or did not elect a corticosteroid injection.

Conclusions

Considered in the light of important limitations of this data including the reliance on patient recall and the limited response rate to the survey, the data are still intriguing. At least in one surgeon’s practice, most informed patients initially elect symptomatic treatment, and most experience symptom resolution within one year.

Keywords: DeQuervain’s syndrome, tendinosis, patient-centered care, shared decision making

Full Text

The Full Text of this article is available as a PDF (93.0 KB).

References

  • 1.Christie B.G. Local hydrocortisone in de Quervain’s disease. BMJ. 1955;1(4929):1501–1503. doi: 10.1136/bmj.1.4929.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Piver J.D., Raney R.B. De Quervain’s tendovaginitis. Am J Surg Mar. 1952;83(5):691–694. doi: 10.1016/0002-9610(52)90304-8. [DOI] [PubMed] [Google Scholar]
  • 3.Lamphier T.A., Long N.G., Dennehy T. De Quervain’s disease: an analysis of 52 cases. Ann Surg Dec 13. 1953;8(6):832–841. doi: 10.1097/00000658-195312000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.McKenzie J.M. Conservative treatment of de Quervain’s disease. Br Med J Dec 16. 1972;4(5841):659–660. doi: 10.1136/bmj.4.5841.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sawaizumi T., Nanno M., Ito H. De Quervain’s disease: efficacy of intra-sheath triamcinolone injection. Int Orthop Apr. 2007;31(2):265–268. doi: 10.1007/s00264-006-0165-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Capasso G., Testa V., Maffulli N., et al. Surgical release of de Quervain’s stenosing tenosynovitis postpartum: can it wait? Int Orthop. 2002;26(1):23–25. doi: 10.1007/s00264-001-0302-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Avci S., Yilmaz C., Sayli U. Comparison of nonsurgical treatment measures for de Quervain’s disease of pregnancy and lactation. J Hand Surg [Am] Mar. 2002;27(2):322–324. doi: 10.1053/jhsu.2002.32084. [DOI] [PubMed] [Google Scholar]
  • 8.Sakai N. Selective corticosteroid injection into the extensor pollicis brevis tenosynovium for de Quervain’s disease. Orthopedics Jan. 2002;25(1):68–70. doi: 10.3928/0147-7447-20020101-19. [DOI] [PubMed] [Google Scholar]
  • 9.Rankin M.E., Rankin E.A. Injection therapy for management of stenosing tenosynovitis (de Quervain’s disease) of the wrist. J Natl Med Assoc Aug. 1998;90(8):474–476. [PMC free article] [PubMed] [Google Scholar]
  • 10.Zingas C., Failla J.M., Holsbeeck M. Injection accuracy and clinical relief of de Quervain’s tendinitis. J Hand Surg [Am] Jan. 1998;23(1):89–96. doi: 10.1016/S0363-5023(98)80095-6. [DOI] [PubMed] [Google Scholar]
  • 11.Weiss A.P., Akelman E., Tabatabai M. Treatment of de Quervain’s disease. J Hand Surg [Am] Jul. 1994;19(4):595–598. doi: 10.1016/0363-5023(94)90262-3. [DOI] [PubMed] [Google Scholar]
  • 12.Anderson B.C., Manthey R., Brouns M.C. Treatment of De Quervain’s tenosynovitis with corticosteroids. A prospective study of the response to local injection. Arthritis Rheum Jul. 1991;34(7):793–798. doi: 10.1002/art.1780340703. [DOI] [PubMed] [Google Scholar]
  • 13.Richie C.A., 3rd, Briner W.W., Jr Corticosteroid injection for treatment of de Quervain’s tenosynovitis: a pooled quantitative literature evaluation. J Am Board Fam Pract Mar–Apr. 2003;16(2):102–106. doi: 10.3122/jabfm.16.2.102. [DOI] [PubMed] [Google Scholar]
  • 14.Lane L.B., Boretz R.S., Stuchin S.A. Treatment of de Quervain’s disease:role of conservative management. J Hand Surg [Br] Jun. 2001;26(3):258–260. doi: 10.1054/jhsb.2001.0568. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Hand and Microsurgery are provided here courtesy of Elsevier

RESOURCES